| Daniel R Seward, NP | |
|
827 N Pine St, Gramercy, LA 70052-3659 | |
| (225) 869-9200 | |
| (225) 869-9241 |
| Full Name | Daniel R Seward |
|---|---|
| Gender | Male |
| Speciality | Clinical Nurse Specialist - Gerontology |
| Location | 827 N Pine St, Gramercy, Louisiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326464017 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364SG0600X | Clinical Nurse Specialist - Gerontology | AP07729 (Louisiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Daniel R Seward, NP 827 N Pine St, Gramercy, LA 70052-3659 Ph: (225) 869-9200 | Daniel R Seward, NP 827 N Pine St, Gramercy, LA 70052-3659 Ph: (225) 869-9200 |
News Archive
Chromium supplements are widely consumed for their antidiabetic activity as chromium(III) enhances the insulin sensitivity of cells. In particular, orthomolecular practitioners believe in the beneficial effects of providing the body with extra amounts of essential trace elements.
Advanced Cell Diagnostics Inc. (ACD), a leader in the field of molecular pathology and developer of cell and tissue-based analysis tools, has announced that its RNAscope® RNA in situ hybridization technology has reached two major milestones. In just three years, over 100 peer-reviewed papers featuring the technology have been published, and with the significant increase in use of RNAscope, ACD has now built a library of over 4000 target probes for numerous species. Probes are designed to order in under two weeks, and in just six months the library has grown by over 1500, reflecting the wide interest in ACD's breakthrough technology.
A University of Colorado Cancer study published today in the Journal of the American Medical Informatics Association describes a new tool that interprets the raw data of whole exome tumor sequencing and then matches the cancer's unique genetics to FDA-approved targeted treatments.
The World Health Organization (WHO) and more than 20 international partners are today launching a comprehensive package of measures to help national authorities safeguard their populations from the dangers of counterfeit medicines.
Health officials in the UK are warning blood donors that three patients developed the human form of mad cow disease after receiving blood from a possible one hundred people, some of whom are suspected of carrying the deadly agent.
› Verified 4 days ago